GCG and type 2 diabetes mellitus: In a meta-analysis comparing SGLT2i and incretin modulator combination therapy to SGLT2i alone or as an add-on to metformin, the combination therapy with an incretin modulator was found to provide additional benefit in the treatment of T2DM, especially in Asians [9].